日韩情欲综合福利久久电影_榴莲视频在线观看卍_夜色福利院在线观看_国产精品 不卡_无码精品人妻一区二区三区在线_99韩国日本欧美国产_欧美一级特黄大片做受_午夜福利麻豆精品_人妻AV无码系列一_亚洲Aⅴ天堂Av天堂无码不卡

Industry Dynamics

Industry News

04-10

2023

Pharming announces US FDA approval of Joenja? (leniolisib) as the first and only treatment indicated for APDS

March 24, 2023 -- Pharming Group N.V. (“Pharming” or “the Company”)(EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) has approved Joenja? (leniolisib) for the treatment of ……

03-27

2023

Pharming announces US FDA approval of Joenja? (leniolisib) as the first and only treatment indicated for APDS

March 24, 2023 -- Pharming Group N.V. (“Pharming” or “the Company”)(EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) has approved Joenja? (leniolisib) for the treatment of ……

03-13

2023

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

MIAMI, March 08, 2023 – OPKO Health, Inc. (NASDAQ: OPK) today announced that ModeX Therapeutics, Inc., an OPKO Health company, entered into an exclusive worldwide license and collaboration agreement with Merck, known as ……

02-03

2023

FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis

February 02, 2023 -- Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for……

01-31

2023

Stemline Therapeutics, a Subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU? (elacestrant)

January 30, 2023 -- Stemline Therapeutics (“Stemline”), a wholly-owned subsidiary of the Menarini Group, announced today that the U.S. Food and Drug Administration (FDA) has approved ORSERDU for the treatment of postmeno……

01-09

2023

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

January 06, 2023 -- Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of……

< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 >

Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號(hào)-1